Even if STAG2 and TP53 mutations are associated with a more aggressive disease, their low frequency cannot account for the high rate of metastasis, further reinforcing the idea that epigenetic regulation of gene expression plays a major role in in EWS tumor progression. The gene discussed is TP53; the disease is neoplasm.